Journal profile · Biochemistry, Genetics and Molecular Biology-General Biochemistry, Genetics and Molecular Biology
Journal of BioX Research
ISSN 2096-5672 · eISSN 2577-3585 · Wolters Kluwer Health · United States
Journal of BioX Research: CAS Zone 4 · Biology (2026 Xinrui edition); diamond open access (no APC); no APC; review about 10 weeks (community reports); 45 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of BioX Research is published by Wolters Kluwer Health and is classed under Biology in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Hearing, Cochlea, Tinnitus, Genetics, Cancer-related molecular mechanisms research and Nanoparticle-Based Drug Delivery, together about 21.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Bio-X Research is devoted to publishing peer-reviewed, high quality, original papers in a variety of fields at the cross boundaries between biology and medicine. The journal focuses on the development and application of cutting-edge methods in genomics, transcriptomics, proteomics and other “omics.” It provides the most comprehensive coverage in interdisciplinary research, spanning significant technical developments and applications of “omics” platforms in every area of etiology, pathophysiology, clinical treatment, and prevention of complex diseases. It publishes scientific investigation of the highest quality in the broad field of complex diseases, such as tumors, diabetes, hypertension, and so on. The Journal of Bio-X Research strives to publish original research papers as well as review articles of high quality across the full gamut of the biomedical sciences. It is particularly interested in (but not limited to) interdisciplinary studies that apply expertise in biology, clinical and basic medicine, physical science, computer science, engineering and other fields to advance the understanding and treatment of disease.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-General Biochemistry, Genetics and Molecular Biology
Editor-in-chief Lin HePublisher website
Editorial board by country: 35 in mainland China (about 69%); most named Mainland China 35, United States 12, France 1, Finland 1, Singapore 1 (51 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hearing, Cochlea, Tinnitus, GeneticsNeuroscience9.2%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology6.5%
- Nanoparticle-Based Drug DeliveryMaterials Science5.9%
- SARS-CoV-2 and COVID-19 ResearchMedicine5.2%
- Liver Disease Diagnosis and TreatmentMedicine4.6%
- Vestibular and auditory disordersNeuroscience4.6%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology4.6%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biochemistry & Molecular Biology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.37LetPub ·
- SNIP 2026-06
- 0.32LetPub ·
- h-index
- 11OpenAlex ·
- i10-index
- 16OpenAlex ·
- 2-year mean citedness
- 2.01OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 39LetPub ·
Articles by year OpenAlex count · 239 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 21 | 21 | 4 |
| 2025 | 45 | 45 | 58 |
| 2024 | 24 | 24 | 119 |
| 2023 | 16 | 16 | 51 |
| 2022 | 16 | 16 | 37 |
| 2021 | 36 | 36 | 72 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 16 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 15,000 words
- Reference style
- Author–date
- Templates
- LaTeX and Word
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Cover letter
- Required
Article types accepted3, with length limits
- editoriale importance to the research community. Editorials should have fewer than 1,000 words total, no abstract, a minimal number of references (no moremain text ≤ 1,000 words
- research articler tables and up to 60 references. Total research article length should be under 15,000 words. Supplementary materials should be limited to information tmain text ≤ 15,000 words
- reviewline of important unresolved questions. Reviews should be no longer than 8,000 words, although longer manuscripts will be considered. Authors mamain text ≤ 8,000 words
Policy excerpts from the journal's websiteAI use, License & copyright, Open access
- AI use
AI tools cannot be authors Model summary
AI-assisted technologies [such as large language models (LLMs), chatbots, and image creators] do not meet the Journal of Bio-X Research's criteria for authorship and therefore may not be listed as authors or coauthors
Source ↗Publisher website ·- License & copyright Copyright and licensing
Copyright held by authors, exclusive license to CMA Model summary
Journal of Bio-X Research content is Open Access, published under a Creative Commons Attribution License (CC BY) on a continuous basis. This means that content is freely available to all readers upon publication and content is published as soon as production is complete. CMA holds an exclusive license to the content, the author(s) hold copyright and retain the right to publish. Visit our FAQ page …
Source ↗Publisher website ·- Open access
Open Access under CC BY license Model summary
Journal of Bio-X Research content is Open Access, published under a Creative Commons Attribution License (CC BY) on a continuous basis.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- United States
- Language
- English
- ISSN
- 2096-5672
- Electronic ISSN
- 2577-3585
- Society / sponsor
- Chinese Medical Association and Chinese Medical Journals Publishing House
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of BioX Research
What CAS zone is Journal of BioX Research in?
In the 2026 Xinrui edition it is in Zone 4 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Journal of BioX Research?
Authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Journal of BioX Research?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 15,000 words; Reference style: Author–date; Templates: LaTeX and Word; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Journal of BioX Research based?
Of the 51 board members whose country the journal's board page names, 35 (about 69%) are in mainland China; the countries named most often are Mainland China (35), United States (12) and France (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of BioX Research?
According to LetPub and DOAJ records, Journal of BioX Research is indexed in ESCI, Scopus and DOAJ.
Is Journal of BioX Research open access, and what is the APC?
Journal of BioX Research is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .